Assignee
SUGEN INC
US·158 granted patents·58 pending applications·8,206 citations·filing 1994–2010
Top patents by PatentIndex Score
216 records- 0199US5804396AAssay for agents active in proliferative disordersSUGEN INC·Filed 1994·Granted Sep 8, 1998·480 cites·18 claims
- 0298US6506763B23-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activitySUGEN INC·Filed 2001·Granted Jan 14, 2003·76 cites·22 claims
- 0398US6133305A3-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activitySUGEN INC·Filed 1998·Granted Oct 17, 2000·125 cites·27 claims
- 0498US5886020A3-(4'-dimethylaminobenzylidenyl)-2-indolinone and analogues thereof for the treatment of diseaseSUGEN INC·Filed 1996·Granted Mar 23, 1999·376 cites·45 claims
- 0598US5883113A3-(4'-Bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of diseaseSUGEN INC·Filed 1996·Granted Mar 16, 1999·373 cites·27 claims
- 0698US5834504A3-(2'-halobenzylidenyl)-2-indolinone compounds for the treatment of diseaseSUGEN INC·Filed 1996·Granted Nov 10, 1998·358 cites·24 claims
- 0798US5792783A3-heteroaryl-2-indolinone compounds for the treatment of diseaseSUGEN INC·Filed 1996·Granted Aug 11, 1998·589 cites·28 claims
- 0898US5789427AMethods and compositions for inhibiting cell proliferative disordersSUGEN INC·Filed 1995·Granted Aug 4, 1998·264 cites·16 claims
- 0998US5773476AMethods and compositions for inhibiting cell proliferative disordersSUGEN INC·Filed 1995·Granted Jun 30, 1998·153 cites·17 claims
- 1097US6573293B2Pyrrole substituted 2-indolinone protein kinase inhibitorsSUGEN INC·Filed 2001·Granted Jun 3, 2003·174 cites·29 claims
- 1197US6239161B1Method and compositions for inhibition of adaptor protein/tyrosine kinase interactionsSUGEN INC·Filed 2000·Granted May 29, 2001·54 cites·9 claims
- 1297US5883116A3-(2'-alkoxybenzylidenyl)-2-indolinone and analogues thereof for the treatment of diseaseSUGEN INC·Filed 1996·Granted Mar 16, 1999·180 cites·26 claims
- 1397US5773459AUrea- and thiourea-type compoundsSUGEN INC·Filed 1995·Granted Jun 30, 1998·117 cites·18 claims
- 1497US5763441ACompounds for the treatment of disorders related to vasculogenesis and/or angiogenesisSUGEN INC·Filed 1995·Granted Jun 9, 1998·111 cites·4 claims
- 1597US5650415AQuinoline compoundsSUGEN INC·Filed 1995·Granted Jul 22, 1997·235 cites·14 claims
- 1696US7125905B2Pyrrole substituted 2-indolinone protein kinase inhibitorsSUGEN INC·Filed 2005·Granted Oct 24, 2006·59 cites·2 claims
- 1796US6683082B2Bicyclic protein kinase inhibitorsSUGEN INC·Filed 2001·Granted Jan 27, 2004·60 cites·34 claims
- 1896US5891917ACertain acrylonitrile-sulfonamide derivativesSUGEN INC·Filed 1997·Granted Apr 6, 1999·75 cites·16 claims
- 1995US6777417B23-(4,5,6,7-tetrahydroindol-2-ylmethylidiene-2-indolinone derivatives as kinase inhibitorsSUGEN INC·Filed 2002·Granted Aug 17, 2004·56 cites·4 claims
- 2095US5990141ATreatment of platelet derived growth factor related disorders such as cancersSUGEN INC·Filed 1995·Granted Nov 23, 1999·189 cites·20 claims
- 2195US5935993ATyrphostin like compoundsSUGEN INC·Filed 1997·Granted Aug 10, 1999·72 cites·16 claims
- 2295US5880141ABenzylidene-Z-indoline compounds for the treatment of diseaseSUGEN INC·Filed 1995·Granted Mar 9, 1999·106 cites·7 claims
- 2395US5792771AQuinazoline compounds and compositions thereof for the treatment of diseaseSUGEN INC·Filed 1995·Granted Aug 11, 1998·155 cites·12 claims
- 2495US5763198AScreening assays for compoundsSUGEN INC·Filed 1994·Granted Jun 9, 1998·155 cites·22 claims
- 2594US7211600B2Methods of modulating c-kit tyrosine protein kinase function with indolinone compoundsSUGEN INC·Filed 2005·Granted May 1, 2007·49 cites·4 claims
- 2694US6653308B23-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitorsSUGEN INC·Filed 2002·Granted Nov 25, 2003·75 cites·40 claims
- 2794US6610688B24-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitorsSUGEN INC·Filed 2000·Granted Aug 26, 2003·74 cites·22 claims
- 2894US5700823ATreatment of platelet derived growth factor related disorders such as cancersSUGEN INC·Filed 1994·Granted Dec 23, 1997·122 cites·23 claims
- 2993US7572924B2Pyrrole substituted 2-indolinone protein kinase inhibitorsSUGEN INC·Filed 2006·Granted Aug 11, 2009·25 cites·3 claims
- 3093US6841579B1Diagnosis and treatment of AUR1 and/or AUR2 related disordersSUGEN INC·Filed 2001·Granted Jan 11, 2005·125 cites·7 claims
- 3193US6677368B24-aryl substituted indolinonesSUGEN INC·Filed 2001·Granted Jan 13, 2004·72 cites·20 claims
- 3293US6326469B1Megakaryocytic protein tyrosine kinasesSUGEN INC·Filed 1995·Granted Dec 4, 2001·184 cites·11 claims
- 3393US6316635B12-indolinone derivatives as modulators of protein kinase activitySUGEN INC·Filed 1999·Granted Nov 13, 2001·87 cites·29 claims
- 3493US6225346B1Tyrphostin like compoundsSUGEN INC·Filed 1999·Granted May 1, 2001·61 cites·9 claims
- 3592US7230098B2Aminoheteroaryl compounds as protein kinase inhibitorsSUGEN INC·Filed 2004·Granted Jun 12, 2007·73 cites·15 claims
- 3692US6103728AQuinazolinesSUGEN INC·Filed 1997·Granted Aug 15, 2000·58 cites·11 claims
- 3792US5602171AMethods of inhibiting phosphatase activity and treatment of disorders associated therewith using naphthopyrones and derivatives thereofSUGEN INC·Filed 1995·Granted Feb 11, 1997·54 cites·12 claims
- 3891US7186716B23-Pyrrol-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitorsSUGEN INC·Filed 2003·Granted Mar 6, 2007·64 cites·12 claims
- 3991US6143765APharmaceutical compositions and methods for modulating signal transductionSUGEN INC·Filed 1998·Granted Nov 7, 2000·44 cites·22 claims
- 4090US7186832B2Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitorsSUGEN INC·Filed 2004·Granted Mar 6, 2007·32 cites·4 claims
- 4190US6696482B2Formulations for hydrophobic pharmaceutical agentsSUGEN INC·Filed 2001·Granted Feb 24, 2004·34 cites·29 claims
- 4290US6696448B23-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitorsSUGEN INC·Filed 2002·Granted Feb 24, 2004·65 cites·4 claims
- 4390US6689806B1Indolinone compounds as kinase inhibitorsSUGEN INC·Filed 2000·Granted Feb 10, 2004·29 cites·19 claims
- 4490US6395734B1Pyrrole substituted 2-indolinone protein kinase inhibitorsSUGEN INC·Filed 1999·Granted May 28, 2002·79 cites·23 claims
- 4590US5942385AMethod for molecular diagnosis of tumor angiogenesis and metastasisSUGEN INC·Filed 1996·Granted Aug 24, 1999·145 cites·19 claims
- 4689US6911446B2Methods of modulating serine/threonine protein kinase function with quinazoline-based compoundsSUGEN INC·Filed 2001·Granted Jun 28, 2005·37 cites·17 claims
- 4789US6207401B1Diagnosis and treatment of AUR-1 and/or AUR-2 related disordersSUGEN INC·Filed 1999·Granted Mar 27, 2001·81 cites·6 claims
- 4889US6147106AIndolinone combinatorial libraries and related products and methods for the treatment of diseaseSUGEN INC·Filed 1997·Granted Nov 14, 2000·37 cites·15 claims
- 4989US5760066ACompounds and methods for inhibiting hyper-proliferative cell growthSUGEN INC·Filed 1996·Granted Jun 2, 1998·30 cites·28 claims
- 5088US6710067B2Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivativesSUGEN INC·Filed 2001·Granted Mar 23, 2004·20 cites·9 claims
Showing the top 50 of 216 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →